本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Centessa Pharmaceuticals plc

12.15
-0.1450-1.18%
盘后12.150.00000.00%18:22 EDT
成交量:63.55万
成交额:770.54万
市值:16.18亿
市盈率:-5.90
高:12.40
开:12.21
低:11.95
收:12.30
数据加载中...
2024/10/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/18

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/09/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/13

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

重要事件披露

Form 8-K - Current report
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/10

重要事件披露

Form 8-K - Current report